Cardiology Flashcards
Indications for SBE prophylaxis (6)
- Prosthetic valve/material
- Previous IE
- Unrepaired cyanotic heart disease
- 1st 6 months post repaired congenital heart disease
- Repaired CHD with residual defects at the site/adjacent to the site of prosthetic patch/device
- Cardiac transplant recipients who develop valvulopathy
Drugs used for SBE prophylaxis
PO amoxil, or IM/IV amp/cef
Class Ia antiarrhythmics
Inhibits Na fast channel, prolongs repolarisation
Used mainly for tachyarrhythmias
Eg. Quinidine, procainamie, dispyramide
Class Ib antiarrhythmics
Inhibits Ns fast channel, shortens repolarisation
Mainly used for ventricular arrhythmias
Lidocaine, mexiletine, phenytoin
Class Ic antiarrhythmics
Inhibits Na channel
Used mainly for tachyarrhythmias
Eg. Flecainide, propafenone
Class II antiarrhythmics
Beta blockers, mainly used for SVT and long QT
Class III antiarrhythmics
Prolong repolarisation
Amiodarone- used for VF, JET, SVT
Class IV antiarrhythmics
Ca channel blockers eg. verapamil
Good for SVT if not caused by WPW
Criteria for further Ix/suppressive therapy for PVCs
2 or more in a row Multiform PVCs Increased ectopic activity with exercise R-on-T phenomenon Extreme frequency >20% of bears Presence of underlying heart disease or prev surgery
Features of SVT on ECG
Narrow complex
Abnormal P-wave axis (normal = positive on I and aVF)
HR relatively unvarying
SVT associated with syncope
AVNRT
Treatment of atrial flutter
Cardioversion, maintenance with digoxin or propanolol
Treatment of AF
Ca channel blockers
LQTS1
KCNQ1 gene
MC genetic cause
Triggered by exercise/stress
Defect in potassium channel
LQTS2
KCNH2 gene
Second MC genetic cause
Potassium channel
LQTS3
SCN5A gene Highly lethal Triggered by sleep Na channel mutation No response to beta blockers- needs ICD
Jervell-Lange-Neilsen syndrome
Congenital LQTS
Associated with hearing loss
Triggered by exercise, emotion
Cardiac defects T21
40-50% AVSD 60% ASD, VSD, PDA 30% TOF 10% Higher risk of pulmonary hypertension, early Eisenmenger syndrome
Truncus arteriosus clinical features
- Time of presentation
- Progression
- OE
- ECG
- CXR
Presents with cyanosis immediately after birth
Progresses to CHF in days to weeks- clinical improvement if pulmonary vascular obstructive disease develops
Bounding peripheral pulses, wide pulse pressure, hyperactiev praecordium, lateral apex beat Systolic click ULSE Single S2 VSD murmur Mitral flow murmur if PBF increased Early diastolic murmur = truncal regurg
Normal QRS axis
BVH 70%
Occasional LAH
Cardiomegaly, increased pulm vascular markings
Can have R aortic arch
Types of truncus arteriosus and implications for pulmonary blood flow
Type 1: Ao and PA off trunk = increased
Type 2: PAs split off Ao = normal
Type 3: PAs split off trunk = normal
Type 4: “pseudotruncus” = PAs split of Ao after the branching arteries = TOF with pulmonary atresia and aortic collaterals = decreased PBF